ReviewBreast cancer research and treatment2018
Clinical implications of germline mutations in breast cancer: TP53.
Katherine Schon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
81 papers cite itlatest 60 shown
this paperpooled itcites it